Manage Account - ModernMedicine

Melanoma Revision
Newly discovered biomarker HDM2 predicts survival
Publish date: February 1, 2003
By: Lisette Hilton
Source:

New York - Researchers have identified a molecular biomarker that was shown in a study to predict survival in melanoma patients, independently of tumor thickness and other known prognostic indicators.

The journal page you requested is now available only to registered Modern Medicine members.

Register Here

Registration is Free!
(and Takes Less than a Minute)

RegisterUS Physicians, click here
for express registration.

RegisterHealthcare Professionals,
click here

Modern Medicine Offers:
» Practice Management Advice
» CME / ICD-9 Coding / Formulary
» Patient Education Handouts
» Peer-reviewed Articles
» Conference Coverage, Email Alerts & More

Click Here to Watch the Tour

Already Registered?

Login Now

Login Email:Password:
Forgot Your Password?Remember me.
Source: Dermatology Times, 2/1/2003
Click here